Brexit Relief For Pharma As EMA Grants Most Batch Testing Exemptions
Executive Summary
Of the 60 or so applications the European Medicine Agency has received from drug companies hoping for more time to move their batch testing sites from the UK to the EU, about 50 have been successful.
You may also be interested in...
EU Urges Regulatory Compliance As UK Flounders In Brexit Chaos
The European Commission says more needs to be done to ensure that all authorized medicines are in compliance with the regulations ahead of Brexit. Meanwhile, machinations in the UK parliament have cast doubt over whether the UK will actually leave the EU at the end of October.
Brexit Transfers Nearly Complete But EMA Staff & Resource Pressures Remain
Practically all centralized marketing authorizations held in the UK have now been moved to the EU, but Brexit and the European Medicines Agency’s relocation to Amsterdam are still causing the EMA some staffing and resource headaches.
‘So Far So Good’: EMA Talks Relocation, Staff Retention, Teleworkers And More
Around 125 staff members have left the European Medicines Agency because of Brexit but the regulator says this should not impact the core services related to the authorization and supervision of medicines for which it is responsible.